Birnbaum, R
Jaffe, A E
Chen, Q
Shin, J H
Schubert, Christian R
O'Donnell, Patricio
Quan, Jie
Wendland, Jens R
Xi, Hualin S
Winslow, Ashley R
Domenici, Enrico
Essioux, Laurent
Kam-Thong, Tony
Airey, David C
Calley, John N
Collier, David A
Wang, Hong
Eastwood, Brian
Ebert, Philip
Liu, Yushi
Nisenbaum, Laura
Ruble, Cara
Scherschel, James
Smith, Ryan Matthew
Qian, Hui-Rong
Merchant, Kalpana
Didriksen, Michael
Matsumoto, Mitsuyuki
Saito, Takeshi
Brandon, Nicholas J
Cross, Alan J
Wang, Qi
Manji, Husseini
Kolb, Hartmuth
Furey, Maura
Drevets, Wayne C
Heon Shin, Joo
Jaffe, Andrew E
Jia, Yankai
Straub, Richard E
Deep-Soboslay, Amy
Hyde, Thomas M
Kleinman, Joel E
Weinberger, Daniel R
Kleinman, J E
Hyde, T M
Weinberger, D R
,
Article History
Received: 2 November 2016
Revised: 29 January 2017
Accepted: 8 March 2017
First Online: 9 May 2017
Competing interests
: CRS, PO, JQ, JRW, HSX and ARW are employees and stockholders of Pfizer. ED, LE and TK-T are employees and stockholders of F Hoffmann-La Roche, AG. DCA, JNC, DAC, HW, BE, PE, YL, LN, CR, JES, RMS and H-RQ are employees and stockholders of Eli Lilly and Company. KM is an employee of TransThera Consulting and an ex-employee of Eli Lilly and Company. MD is an employee and stockholder of H Lundbeck A/S. MM and TS are employees of Astellas Pharma. NJB, AJC and QW are employees and stockholders of AstraZeneca LP. HM, HK, MF and WCD are employees of Janssen Research and Development, LLC, and of Johnson and Johnson, and stockholders of Johnson and Johnson. JHS, AEJ, YJ, RES, AD-S, TMH, JEK and DRW are employees of the Lieber Institute for Brain Development, a non-profit organization. The authors declare no conflict of interest. Funding for the research currently reported is from the Lieber Institute for Brain Development, the BrainSeq Consortium and the Division of Intramural Research Programs, National Institute of Mental Health.